Literature DB >> 18729391

The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles.

Douglas G Mullen1, Ankur M Desai, Jack N Waddell, Xue-Min Cheng, Christopher V Kelly, Daniel Q McNerny, István J Majoros, James R Baker, Leonard M Sander, Bradford G Orr, Mark M Banaszak Holl.   

Abstract

Stochastic synthesis of a ligand coupled to a nanoparticle results in a distribution of populations with different numbers of ligands per nanoparticle. This distribution was resolved and quantified using HPLC and is in excellent agreement with the ligand/nanoparticle average measured by 1H NMR, gel permeation chromatography (GPC), and potentiometric titration, and yet significantly more disperse than commonly held perceptions of monodispersity. Two statistical models were employed to confirm that the observed heterogeneity is consistent with theoretical expectations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729391      PMCID: PMC2652353          DOI: 10.1021/bc8002106

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  21 in total

1.  Array-based electrical detection of DNA with nanoparticle probes.

Authors:  So-Jung Park; T Andrew Taton; Chad A Mirkin
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

Review 2.  Dendritic polymer macromolecular carriers for drug delivery.

Authors:  Anil K Patri; István J Majoros; James R Baker
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

3.  Discrete nanostructures of quantum dots/Au with DNA.

Authors:  Aihua Fu; Christine M Micheel; Jennifer Cha; Hauyee Chang; Haw Yang; A Paul Alivisatos
Journal:  J Am Chem Soc       Date:  2004-09-08       Impact factor: 15.419

Review 4.  Nanotechnology in clinical laboratory diagnostics.

Authors:  Kewal K Jain
Journal:  Clin Chim Acta       Date:  2005-08       Impact factor: 3.786

5.  Rigid, specific, and discrete gold nanoparticle/antibody conjugates.

Authors:  Christopher J Ackerson; Pablo D Jadzinsky; Grant J Jensen; Roger D Kornberg
Journal:  J Am Chem Soc       Date:  2006-03-01       Impact factor: 15.419

6.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  HPLC analysis of PAMAM dendrimer based multifunctional devices.

Authors:  Mohammad T Islam; Istvan J Majoros; James R Baker
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-08-05       Impact factor: 3.205

8.  Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.

Authors:  István J Majoros; Thommey P Thomas; Chandan B Mehta; James R Baker
Journal:  J Med Chem       Date:  2005-09-22       Impact factor: 7.446

9.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice.

Authors:  Thommey P Thomas; Istvan J Majoros; Alina Kotlyar; Jolanta F Kukowska-Latallo; Anna Bielinska; Andrzej Myc; James R Baker
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

10.  Glucose oxidase-magnetite nanoparticle bioconjugate for glucose sensing.

Authors:  Liane M Rossi; Ashley D Quach; Zeev Rosenzweig
Journal:  Anal Bioanal Chem       Date:  2004-09-22       Impact factor: 4.142

View more
  18 in total

1.  Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.

Authors:  Ming-Hsin Li; Seok Ki Choi; Thommey P Thomas; Ankur Desai; Kyung-Hoon Lee; Alina Kotlyar; Mark M Banaszak Holl; James R Baker
Journal:  Eur J Med Chem       Date:  2011-11-23       Impact factor: 6.514

2.  Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Authors:  Douglas G Mullen; Daniel Q McNerny; Ankur Desai; Xue-Min Cheng; Stassi C Dimaggio; Alina Kotlyar; Yueyang Zhong; Suyang Qin; Christopher V Kelly; Thommey P Thomas; Istvan Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2011-03-22       Impact factor: 4.774

3.  Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Authors:  Douglas G Mullen; Mark M Banaszak Holl
Journal:  Acc Chem Res       Date:  2011-08-03       Impact factor: 22.384

4.  Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography.

Authors:  Ankur M Desai; Mark Andreae; Douglas G Mullen; Mark M Banaszak Holl; James R Baker
Journal:  Anal Methods       Date:  2011-01       Impact factor: 2.896

5.  Isolation and characterization of precise dye/dendrimer ratios.

Authors:  Casey A Dougherty; Joseph C Furgal; Mallory A van Dongen; Theodore Goodson; Mark M Banaszak Holl; Janet Manono; Stassi DiMaggio
Journal:  Chemistry       Date:  2014-03-06       Impact factor: 5.236

6.  Isolation and characterization of dendrimers with precise numbers of functional groups.

Authors:  Douglas G Mullen; Emilee L Borgmeier; Ankur M Desai; Mallory A van Dongen; Mark Barash; Xue-min Cheng; James R Baker; Mark M Banaszak Holl
Journal:  Chemistry       Date:  2010-09-17       Impact factor: 5.236

7.  Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.

Authors:  Thommey P Thomas; Melvin Joice; Madhuresh Sumit; Justin E Silpe; Alina Kotlyar; Sophia Bharathi; Jolanta Kukowska-Latallo; James R Baker; Seok Ki Choi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.

Authors:  Douglas G Mullen; Emilee L Borgmeier; Ming Fang; Daniel Q McNerny; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  Macromolecules       Date:  2010-08-24       Impact factor: 5.985

9.  Biophysical characterization of a riboflavin-conjugated dendrimer platform for targeted drug delivery.

Authors:  Amanda B Witte; Christine M Timmer; Jeremy J Gam; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  Biomacromolecules       Date:  2012-01-18       Impact factor: 6.988

Review 10.  Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules.

Authors:  Robert K Delong; Christopher M Reynolds; Yaneika Malcolm; Ashley Schaeffer; Tiffany Severs; Adam Wanekaya
Journal:  Nanotechnol Sci Appl       Date:  2010-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.